Gene · 5142
Papers1,785
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,785
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identified Isosteric Replacements of Ligands' Glycosyl Domain by Data Mining. | ACS Omega | 2023 | 37483233 | PubTator, text mining | PubMed |
| Discovery of 2-(Methylcarbonylamino) thiazole as PDE4 inhibitors via virtual screening and biological evaluation. | J Mol Graph Model | 2023 | 37481883 | PubTator, text mining | PubMed |
| Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes. | J Neuroinflammation | 2023 | 37481642 | PubTator, text mining | PubMed |
| Defining critical illness using immunological endotypes in patients with and without sepsis: a cohort study. | Crit Care | 2023 | 37474944 | PubTator, text mining | PubMed |
| Identification and validation of immune-associated NETosis subtypes and biomarkers in anti-neutrophil cytoplasmic antibody associated glomerulonephritis. | Front Immunol | 2023 | 37465687 | PubTator, text mining | PubMed |
| It Takes Two to Tango! Protein-Protein Interactions behind cAMP-Mediated CFTR Regulation. | Int J Mol Sci | 2023 | 37445715 | PubTator, text mining | PubMed |
| Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions. | Cancers (Basel) | 2023 | 37444436 | PubTator, text mining | PubMed |
| Eco-friendly synthesis of new olanzapine derivatives and evaluation of their anticancer potential. | RSC Adv | 2023 | 37435368 | PubTator, text mining | PubMed |
| Inhibition of phosphodiesterase 4D suppresses mTORC1 signaling and pancreatic cancer growth. | JCI Insight | 2023 | 37427586 | PubTator, text mining | PubMed |
| Novel Anti-Inflammatory Approaches to COPD. | Int J Chron Obstruct Pulmon Dis | 2023 | 37408603 | PubTator, text mining | PubMed |
| Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies. | Dermatol Ther (Heidelb) | 2023 | 37402031 | PubTator, text mining | PubMed |
| Genetic Factors Associated with Suicidal Behaviors and Alcohol Use Disorders in an American Indian Population. | Res Sq | 2023 | 37398076 | PubTator, text mining | PubMed |
| Genetic mechanisms for impaired synaptic plasticity in schizophrenia revealed by computational modelling. | bioRxiv | 2023 | 37398070 | PubTator, text mining | PubMed |
| Difamilast for the treatment of atopic dermatitis. | J Int Med Res | 2023 | 37389929 | PubTator, text mining | PubMed |
MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology. | Viruses | 2023 | 37376663 | PubTator, text mining | PubMed |
| Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers. | Antioxidants (Basel) | 2023 | 37371940 | PubTator, text mining | PubMed |
| The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy? | Cancers (Basel) | 2023 | 37370771 | PubTator, text mining | PubMed |
| GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC. | Cancers (Basel) | 2023 | 37370739 | PubTator, text mining | PubMed |
| Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis. | Front Pharmacol | 2023 | 37324497 | PubTator, text mining | PubMed |
| An overview of human single-cell RNA sequencing studies in neurobiological disease. | Neurobiol Dis | 2023 | 37321420 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5142/papers?page=13